Soma Mandal, MD, MSCP, says removing MHT boxed warnings is overdue but calls for transparency on the FDA's product-specific rationale.
|Articles|April 26, 2022
Coronavirus Omicron variant, vaccine, and case numbers in the US: April 26, 2022
Author(s)Logan Lutton
How many COVID-19 cases were announced today?
Advertisement
The
Here’s the latest data, updated on April 26:
- Positive tests: 81,043,315
- Patient deaths: 991,609
- Total vaccine doses distributed: 723,209,645
- Patients who’ve received the first dose: 257,296,710
- Patients who’ve received the second dose: 219,370,557
- % of population fully vaccinated: 66.1%
- % of infections tied to the Omicron Variant: 100%
Advertisement
Related to this article
CMS' proposed G-codes, which experts stated would cause confusion in combination with the AMA's proposed codes, were not included in the final fee schedule for 2027, according to ACOG.
Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.
Samples from a large UK screening trial supported validation of the investigational Evident ovarian cancer test, according to Dawn Mattoon, PhD.
Lisa Taylor-Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy.
Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.
A recap of the top video interviews from Contemporary OB/GYN's coverage of The Menopause Society 2026 Annual Meeting in San Diego.
Susan Reed, MD, MPH, MS, and Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, weigh in on FDA boxed warning removals for menopausal hormone therapy.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
2
Reactions to FDA's boxed warning removals for menopausal hormone therapy
3
Top headlines in women's health from October 2026
4
Q&A: Peter Hsin, BS, on perioperative ketamine and early postpartum depression
5